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Abstract
Background: Prenatal ethanol exposure during pregnancy induces a spectrum of mental and physical disorders
called fetal alcohol spectrum disorder (FASD). The central nervous system is the main organ influenced by FASD,
and neurological symptoms include mental retardation, learning abnormalities, hyperactivity and seizure
susceptibility in childhood along with the microcephaly. In this study, we examined whether ethanol exposure
adversely affects the proliferation of NPC and de-regulates the normal ratio between glutamatergic and GABAergic
neuronal differentiation using primary neural progenitor culture (NPC) and in vivo FASD models.
Methods: Neural progenitor cells were cultured from E14 embryo brain of Sprague-Dawley rat. Pregnant mice and
rats were treated with ethanol (2 or 4 g/kg/day) diluted with normal saline from E7 to E16 for in vivo FASD animal
models. Expression level of proteins was investigated by western blot analysis and immunocytochemical assays.
MTT was used for cell viability. Proliferative activity of NPCs was identified by BrdU incorporation,
immunocytochemistry and FACS analysis.
Results: Reduced proliferation of NPCs by ethanol was demonstrated using BrdU incorporation,
immunocytochemistry and FACS analysis. In addition, ethanol induced the imbalance between glutamatergic and
GABAergic neuronal differentiation via transient increase in the expression of Pax6, Ngn2 and NeuroD with
concomitant decrease in the expression of Mash1. Similar pattern of expression of those transcription factors was
observed using an in vivo model of FASD as well as the increased expression of PSD-95 and decreased expression
of GAD67.
Conclusions: These results suggest that ethanol induces hyper-differentiation of glutamatergic neuron through
Pax6 pathway, which may underlie the hyper-excitability phenotype such as hyperactivity or seizure susceptibility
in FASD patients.
Background
Fetal alcohol spectrum disorder (FASD) is a spectrum of
mental and physical disorders associated with prenatal
exposure to alcohol during pregnancy, which affects one
in every 100 live births in United states and Europe [1].
Ethanol has well-known teratogenic effects by mechan-
isms including induction of apoptosis and inhibition of
proliferation, migration, differentiation, and other
cellular functions during developmental period [2-5]. In
addition, ethanol exposure influences membrane-
associated receptor signaling pathways [6], cell adhesion
[7,8], and the binding of transcription factors [9].
The central nervous system is the main organ affected
by FAS [10-13], and neurological symptoms include
mental retardation, learning disabilities and ADHD-like
symptoms such as hyperactivity in childhood [14,15].
Children with FASD usually exhibit smaller brain size,
so-called microcephaly [16]. Recent studies suggest that
alcohol interferes with the migration and organization of
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deficits within the brain.
Neural stem/progenitor cells (NPCs) are self-
renewable cells in the CNS. NPC is able to differentiate
into specific cell types including neuron during the
brain developmental period by its multi-potent capacity.
Disorder of neural development might be induced by
the de-regulation of NPC proliferation and differentia-
tion, which may cause bigger influence in the entire
architecture of the brain compared with the neurotoxic
effects of risk factors in later period of life. This is espe-
cially true considering the fact that neuron is amitotic
after differentiation [17], although there are a few
known exceptions [18]. Therefore it is reasonable idea
that prenatal ethanol affects overall architecture and size
of the brain by influencing the proliferation and differ-
entiation properties of NPCs during developmental peri-
ods. Regarding the effect of ethanol on NPCs, it inhibits
the proliferation of adult hematopoietic stem cells as
well as NPCs [19,20] and suppresses neurogenesis
[21,22] in adolescent and adult brain. However, rela-
tively few things are known regarding the effect of etha-
nol consumption during gestational periods on NPC
proliferation and differentiation.
In addition to the regulation of proliferation of NPCs,
balance between excitatory and inhibitory neurons in
the brain plays a very important role in neurological
function of brain. For example, imbalance between exci-
tatory and inhibitory synapses is related to autistic
symptoms [23]. This imbalance of excitation and inhibi-
tion could be due to the increased excitatory signaling,
or to a reduction in inhibition due to a reduction in
inhibitory signaling [24]. Increasing the numerical or
functional balance of excitatory vs. inhibitory cells can
lead to a hyper-excitable state, which might be an
underlying neurobiological feature in the manifestation
of neurological abnormalities such as hyperactivity
symptoms of FASD.
Excitatory neuronal differentiation from NPC is acti-
vated by expression of specific transcription factors
which act as proneural genes. Proneural genes are both
necessary and sufficient to initiate the development of
neuronal lineages and to promote the generation of
progenitor cells that have a capacity to differentiate.
Importantly, proneural genes have been shown to have
information into the neurogenesis [25] and to contri-
bute to the control of progenitor-cell identity [26].
Current studies focus on understanding the mechan-
isms of the multiple functions of proneural genes in
neural development [27]. For example, Pax6, a pro-
neural gene originally implicated in eye development,
has been suggested in the regulation of glutamatergic
neuronal fate. Pax6 induces expression of Ngn2 and
NeuroD, which are involved in glutamatergic
differentiation and reduces expression of Mash1, which
induces GABAergic differentiation.
In this study, we examined the effect of prenatal etha-
nol consumption on proliferation of NPCs along with
the regulation of excitatory and inhibitory neuronal
differentiation.
Methods
Materials
Hanks balanced salt solution (HBSS), Dulbecco’sM o d i -
fied Eagle’s medium/F12 (DMEM/F12), fetal bovine
serum (FBS), penicillin/Streptomycin, and 0.25% Tryp-
sin-EDTA were purchased from GibcoBRL (Grand
Island, NY). poly-l-ornithine, Tween® 20 were purchased
f r o mS i g m a( S t .L o u i s ,M O ) .E C L ™ Western blotting
detection reagents were obtained from Amersham Life
Science (Arlington Heights, IL). B-27 supplement were
purchased from Invitrogen (Carlsbad, CA).
Antibodies were purchased from the following compa-
nies: anti-b-actin from Sigma (St. Louis, MO), phospho
histone H3 antibody from Upstate Biologicals (Lake
P l a c i d ,N Y ) ,n e u r o n a lc l a s sI I Ib- tubulin (Tuj-1) anti-
body from Covance (Richmond, CA), antibodies against
nestin, synaptophysin, neuN, Pax6, Neurogenin2 (ngn2)
and GAD67 from Millipore (Temecula, CA) and antibo-
dies against Mash1/Achaete-scute homolog 1(Mash1),
PSD95, NeuroD1, vGluT1, PCNA and BrdU were
obtained from Abcam (Cambrigeshire, England).
Culture of primary neural stem cells
Neural progenitor cell culture was prepared form E14
embryo SD rat according to previously published proce-
dure [28,29], which was slightly modified by us [30]. In
brief, cortices were dissociated into single cells by pipet-
ting several times and passed through 40 μm cell strai-
ner (BD falcon, BD science, Franklin Lakes, NJ).
Dissociated single cells were incubated with Dulbecco’s
modified Eagle’s medium/F12 (DMEM/F12) containing
B-27 supplement with 20 ng/ml EGF (Upstate) and 10
ng/ml FGF (Invitrogen) at 37°C for 4 days in 5% CO2
incubator. The cells grew into floating neurosphere were
dissociated with trypsin-EDTA (GibcoBRL) and then
resulting single cells were counted and plated on poly-l-
ornithine (Sigma) coated plate with DMEM/F12 media
containing B-27 supplement for further experiments.
In vivo ethanol treatment
Pregnant mice and rats were obtained from Daehan Bio
Link (Daejeon, Korea) at gestation day (E2) and stabi-
lized under environmental controlled rearing system
maintained 12 hr light-dark cycle for 4 days. The ani-
mals were treated with ethanol (Hayman, UK; 2 or
4 g/kg/day; 25 v/v %) diluted with normal saline from
E7 to E16 via intragastric intubation. Control groups
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delivered in two halves each in the morning and evening
to minimize the deleterious effects of binge alcohol
drinking. At E12, P3 and 6 weeks after birth, brain was
removed from the offsprings and analyzed for target
protein expression by Western blot or immunohisto-
chemistry. All animal experiments were conducted in
accordance with the approved procedure either by the
Konkuk University or Seoul National University Animal
Care and Experimentation Committee.
Western blot analysis
Cells were washed twice with PBS and lysed with 2×
SDS-PAGE sample buffer. An aliquot containing 50 μg
of total protein was separated by 10% SDS-PAGE and
transferred to nitrocellulose membranes. The mem-
branes were blocked with 1% polyvinylalcohol in PBS
containing 0.2% tween-20 for 10 min. The membranes
were incubated at 4°C for overnight with first antibodies
directed against target proteins such as nestin, tuj-1,
pax6, ngn2, neuroD, mash1, PSD95, GAD67(all 1:5000),
which were diluted in blocking buffer (5% or 1% skim
milk in PBS-Tween (0.2% tween-20)). Membranes were
washed 3 times with PBS-Tween for 10 min, and then
incubated with species specific peroxidase-conjugated
secondary antibodies (Santa Cruz, CA), which were
diluted in blocking buffer (5% skim milk in PBS-Tween)
for 2 hrs at room temperature. Specific bands were
detected using the ECL system (Amersham) and
exposed to Bio-Rad electrophoresis image analyzer (Bio-
Rad, Hemel Hampstead, UK).
MTT assay
To determine the viability of cell, we used MTT assay.
NPCs were incubated for 60 min with 500 μg/ml MTT
reagent (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zlium bromide, a tetrazole, Sigma) in the dark. After
incubation, medium was removed and the formazan dye
was extracted using 100% ethanol. The absorbance was
determined using a microplate reader (Spectrafluor,
Tecan Trading AG, Austria) at 590 nm.
BrdU (5-bromo-2-deoxyuridine, Bromodeoxyuridine)
incorporation
Proliferation of NPCs was measured using BrdU ELISA
kit (Roche, Mannheim, Germany) following manufac-
turer’s instruction. After ethanol treatment, cells
grown in 96-well plate were incubated at 37°C for 24
hrs with 10 μM of BrdU labeling solution. After
removing BrdU labeling solution, cells were fixed for
30 min at room temperature. Fixative was washed
away and 100 μl of anti-BrdU solution was added for
2 hrs. After washing with PBS for three times, colors
were developed using anti-BrdU-POD solution and
w e r ei n c u b a t e df o r1 0 - 3 0m i na tr o o mt e m p e r a t u r e .
We added 1N HCl (50 μl/well) until the absorbance
was sufficient for photometric detection and then the
absorbance was measured using an ELISA reader
(Spectrafluor) at 450 nm.
Fluorescent Activated Cell Sorting Analysis (FACS)
Cell cycle of NPCs was analyzed by FACS analysis. Pla-
ted single cells were trypsinized with trypsin-EDTA and
were suspended in PBS with 1% FBS. Suspension was
centrifuged at 3000 rpm for 3 min and supernatant was
removed as completely as possible without disturbing
the pellet. Suspended cell was fixed with 70% ethanol in
PBS and was incubated for overnight at 4°C. Superna-
tants were removed after centrifugation as above and
cells were incubated with 50 μg/ml propidium iodide
(Sigma) and 100 μg/ml ribonuclease A (Sigma) in 500 μl
PBS with 1% FBS. Samples were kept at room tempera-
ture, protected from the light for 30-40 min prior to
analysis. Cell cycle of NPCs was analyzed using an
FACS cytometer (BD bioscience).
Immunocytochemistry
Cultured NPCs or differentiated cells on cover glass
(Fisher Scientific, PA) were washed and fixed with 4%
paraformaldehyde at 4°C for 2 hrs. The cells were trea-
ted with 0.3% Triton X-100 for 15 min at room tem-
perature and were blocked for 30 min with blocking
buffer (1% BSA, 5% FBS in PBS) at room temperature.
The cells were incubated for overnight at 4°C with
primary antibodies against phospho-histone H3 (rabbit,
1:500), tuj-1 (rabbit, 1:500), nestin (mouse, 1:500),
GAD67 (mouse, 1:500), and neuroD (rabbit, 1:500)
diluted in blocking buffer, and were washed with wash-
ing buffer (0.1% BSA, 0.5% FBS in PBS) for 3 times.
Secondary antibodies conjugated with TMRE (anti-
mouse, 1:100) or FITC (anti-rabbit, 1:100 were diluted
in blocking buffer and incubated for 2 hrs at room tem-
perature in the dark condition.), In some cases, nucleus
was co-stained with DAPI (4’-6-diamidino-2-phenylin-
dole) staining solution (1:100, Invitrogen). After washed
3 times with washing buffer, the cover glass were
mounted in Vectashield (Vector laboratories, Burlin-
game, CA) and viewed with a confocal microscope
(TCS-SP, Leica, Heidelberg, Germany).
Statistical analysis
Data were expressed as the mean ± standard error of
mean (S.E.M) and analyzed for statistical significance
using one way analysis of variance (ANOVA) followed
by Newman-Keuls test as a post hoc test and a P value
< 0.05 was considered significant.
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Ethanol inhibited proliferation of neural stem cell
We first determined the effect of ethanol on NPCs via-
bility. Ethanol did not show toxicity to NPCs culture,
which was determined by MTT assay at all concentra-
tion and duration we used in this study (Figure 1A).
To determine anti-proliferative effect of ethanol, BrdU
incorporation assay was performed. BrdU is a synthetic
nucleoside that is an analogue of thymidine, which is
commonly used for the detection of proliferating cell.
The BrdU assay measures cells that have synthesized
DNA within a given time period. The percentage of
BrdU-positive cells was reduced compared with control
after treatment with 10 and 50 mM ethanol (Figure 1B).
The inhibition of BrdU incorporation by ethanol showed
concentration dependency and the extent of inhibition
was higher when the cells were treated with ethanol for
3 days.
To further investigate the anti-proliferative effect of
ethanol, cells were immunostained for phospho-histone
H3 (pH3) and Proliferating Cell Nuclear Antigen
(PCNA), as markers for dividing cells. The number of
pH3 or PCNA-positive cell was significantly reduced by
ethanol treatment in a concentration dependent manner
(Figure 1C) suggesting that ethanol inhibits the cell
cycle progression of NPCs culture.
To determined mechanism of anti-proliferative effect
of ethanol, we performed FACS analysis. Quantitative
graph represented relative proportion of sub G1, S and
G2/M phases in control and 10 or 50 mM ethanol trea-
ted groups. In quantitative analysis of FACS data, etha-
nol treatment to NPCs culture slightly increased cells in
sub G1 phase and decreased the proportion of cells in
G2/M phase as compared with control (Figure 1D) sug-
gesting the inhibitory role of ethanol during G2/M cell
cycle progression of NPCs culture.
Ethanol increased neurogenesis
We next examined the differentiation of NPCs by
Western blot analysis and immunocytochemistry assays
using cell specific marker proteins. Nestin was used as
an undifferentiated neural stem cell marker, and Tuj-1
was used for neuron. In western blot analysis, the level
of nestin was decreased on day 3 after ethanol treatment
(Figure 2A), which is consistent with the inhibitory
effect of ethanol on NPCs proliferation as described in
Figure 1. On the contrary, the level of Tuj-1 was signifi-
cantly increased about 2-fold compared to control with
50 mM of ethanol treatment (Figure 2B). These results
suggest that ethanol induced neural stem cell differen-
tiation into neuron while inhibiting the proliferation of
NPCs in the early stage of neurogenesis. In immuno-
chemical staining, the number of nestin positive cells
was decreased by ethanol treatment while Tuj-1 positive
cells showed increased number and length of neural
processes with stronger immunoreactivity (Figure 2C).
The differences in neural differentiation by ethanol were
disappeared if we extended the differentiation period to
7 days suggesting that ethanol may promote the kinetics
of neural differentiation but not the neural fate (neuron
Figure 1 Ethanol inhibited the proliferation of NPCs. We treated
two concentrations (10 mM and 50 mM) of ethanol to rat primary
NPCs culture for 1 or 3 days. Cell viability (A) and BrdU
incorporation (B) was examined as described in methods. (A) MTT
analysis. Ethanol did not induce cellular toxicity against NPCs. (B)
Both on day 1 and 3, BrdU incorporation was inhibited by ethanol
treatment in a concentration-dependent manner. (C) To investigate
inhibitory effect of ethanol on cell proliferation,
immunocytochemistry against pH3 or PCNA was performed on
day 3. The number of pH3-positive cells as well as PCNA positive
cells was reduced by ethanol treatment. (D) FACS analysis of cell
cycle. FACS analysis was performed as described in methods 4 hr
after ethanol treatment on NPCs culture. Ethanol treatment
decreased cells in G2/M phase as compared with control. Values are
expressed as the mean ± S.E.M. **, *** p < 0.01 and < 0.001 vs.
control (n = 5 for A, B and C. n = 3 for D).
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experimental condition.
Glutamatergic neuronal differentiation was induced by
ethanol through Pax6 expression
To investigate whether ethanol alters the balance of excita-
tory/inhibitory neuronal differentiation, we first examined
the level of expression of proneural genes after ethanol
treatment. Proneural genes such as Pax6, Ngn2 and Neu-
roD are expressed in stepwise pattern during developmen-
tal periods and have been suggested to promote excitatory
neuronal differentiation. Expression of Pax6, Ngn2 and
NeuroD was increased 1 day after ethanol treatment com-
pared to control (Figure 3A). However, the level of Mash1,
which have been implicated in inhibitory neuronal differ-
entiation, was decreased in the same condition
(Figure 3A). These data suggest that the number of excita-
tory neuron might be higher than that of inhibitory neu-
ron and we performed Western blot analysis using the
marker protein, PSD95 as a glutamatergic neuronal
Figure 2 Ethanol induced early neurogenesis from NPCs.( A )
Expression of Nestin and (B) Tuj-1 was determined by Western blot
after ethanol treatment. Ethanol (50 mM) decreased the expression
of Nestin to 70% of control level and increased that of Tuj-1 to
170% of control value. (C) Immunocytochemical staining of nestin
and Tuj-1. Similar results were obtained as Western blot. Values are
expressed as the mean ± S.E.M. *, ** p < 0.05 and < 0.01 vs. control
(n = 5).
Figure 3 Increased expression of Pax6 and glutamatergic
neuronal differentiation by ethanol treatment. NPCs were
treated with ethanol and Western blot and immunocytochemistry
were performed to determine the expression of Pax6 and
downstream transcription factors (A) as well as glutamatergic and
GABAergic neuronal subtype markers (B). (C) Immunocytochemical
staining of GABAergic marker GAD67 and a regulator of excitatory
neuronal differentiation, NeuroD, in NPCs treated with ethanol. (D)
Triple immunocytochemical staining of neuronal marker Tuj1 (red)
and vGluT1 (blue), a marker for glutamatergic neuron along with
BrdU (green) staining, a marker for proliferated cells. Most of the
vGluT1-positive cells were co-localized with BrdU staining.
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level of PSD95 was significantly increased in neurons dif-
ferentiated for 7 days from NPCs by single ethanol treat-
ment. On the contrary, the level of GAD67 was decreased
in the same condition (Figure 3B). Immunocytochemistry
also showed increased expression of NeuroD and
decreased expression of GAD67 by ethanol treatment (Fig-
ure 3C). Immunocytochemical reactivity for vGluT1, a
marker for glutamatergic neuron, also increased by etha-
nol treatment (Figure 3D). Positive cells against vGluT1
were also positive against BrdU staining, suggesting that
neural progenitor cells are differentiated into glutamater-
gic neuron. Altogether, these results suggest that exposure
to ethanol induced early neurogenesis while inhibiting
proliferation of NPCs, and modified the balance of gluta-
matergic/GABAergic neuronal differentiation.
Increased expression of Pax6 and glutamatergic neuronal
differentiation by prenatal ethanol exposure in vivo
Next, we examined the effect of ethanol on neural stem
cell differentiation in FASD animal models. Pregnant
mice were administered with ethanol (2 g/kg and
4 g/kg) on E6 until E16 and we investigated the expres-
sion of Pax6, Ngn2 and NeuroD by Western blot. The
level of these transcription factors was significantly
increased in the brain of E12 embryonic mice from
dams ingested ethanol (Figure 4A). At postnatal day 3,
expression level of Pax6 and Ngn2 was decreased both
in control and ethanol groups almost below the detec-
tion limit and the level of NeuroD, which modulates
neuronal maturation, was significantly increased in post-
natal period although there is not much difference
between treatment groups (Figure 4A). We next exam-
ined the expression level of PSD95, GAD67, synapto-
physin and Tuj-1 in the several brain regions of FASD
rat animal models at 6 weeks, the time point that the
neural developments are already completed. Compared
to the control group, the level of PSD95 was signifi-
cantly increased in cortex and to a lesser extent in hip-
pocampus, but not in striatum. Likewise, we observed a
slight increase in the expression level of synaptophysin
in cortex and hippocampus of prenatally ethanol
exposed rats. On the other hand, the level of GAD67
was reduced in the cortex and hippocampus of prena-
tally ethanol-treated group. The level of Tuj-1 and b-
actin determined by Western blot (Figure 4B) as well as
NeuN and Tuj-1 immunohistochemical staining (data
not shown) did not show significant difference in all
brain regions examined, which suggest that the total
number of neuron is not different between control and
prenatally ethanol-exposed groups. Altogether, these
results suggest that prenatal ethanol exposure induced
glutamatergic neuronal differentiation through increased
expression of Pax6, Ngn2 and NeuroD in both in vitro
and in vivo conditions.
Discussion
Excess alcohol consumption during pregnancy exerts
teratogenic effects on the fetus, including abnormalities
of the central nervous system, general growth retarda-
tion and craniofacial defects, which are collectively
called FASD [31-35]. Recently, it becomes clear that
prenatal exposure to ethanol may induce alterations in
neurobehavioral phenotypes or performance of executive
functions in the offsprings without obvious physical
deformation such as facial changes. It is self-evident that
the neuropathological changes may involve either or
both the alterations in neural stem cell proliferation and
differentiation, and a few studies investigated the effects
of prenatal alcohol exposure on the NPCs proliferation
and neuronal development. Previous studies have sug-
gested that prenatal ethanol exposure may affect CNS
development, which range from the apoptotic death of
stem cell population to modulation of cell cycle progress
during neurulation or neurogenesis periods [33,36-38].
More recently, it has been suggested that alcohol may
affect the differentiation of cortical neurons in vitro [37]
as well as hippocampal neurons in vivo [39]. In addition,
alterations in astroglial differentiation have also been
Figure 4 Increased expression of Pax6 and glutamatergic
neuronal differentiation in vivo by ethanol treatment. (A)
Expression level of Pax6, Ngn2 and NeuroD was determined by
Western blot as described, which showed significant increase during
embryonic stage by in vivo ethanol treatment in FASD animal
model. (B) Expression level of PSD95, GAD67, synaptophysin and
Tuj-1 in the 6 week-brain of FASD animal model. Expression of
PSD95 was up-regulated in the cortex and striatum. On the
contrary, GAD67 expression was decreased in the cortex.
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inhibited proliferation of NPCs and induced early differ-
entiation of neuron. It also modulated excitatory/inhibi-
tory neuronal differentiation both in vitro and in vivo,
which might be related to the hyper-excitability of pre-
natally ethanol-exposed subjects.
Although increased apoptosis [42], interruption to cell
proliferation [43], and impaired protein and DNA synth-
esis [44] have been reported as a possible mechanism
underlying the teratogenic effect of ethanol, mechanisms
regulating the neurological symptoms of FASD have not
been clearly explained yet. Suggested mechanisms
includes DNA methylation [45,46], modulation of phos-
pholipase D signaling [47], apoptosis [48-50], and altera-
tion in neuronal migration [51] as well as changes in
neurotransmitter systems [52].
Excitatory neuronal differentiation from NPCs is acti-
vated by expression of specific transcription factors. Past
studies emphasized the role of Pax6 in eye development
[53,54]. Recently, another role of Pax6 as a neuronal
subtype determinant is magnified. Pax6 is expressed at
NPCs committed to glutamatergic neuronal fate [55].
Pax6 induces the expression of Ngn2 and NeuroD,
which again involved in glutamatergic differentiation,
while reduces the expression of Mash1, an enhancer of
GABAergic differentiation [56-60].
However, it should be remembered that the expression
of Pax6 is also associated with the regulation of stem
cell proliferation and brain microcephaly. In the neocor-
tex, functional loss of Pax6 results in microcephaly
which might be induced by an abnormal development
of the secondary progenitor population of the subventri-
cular zone (SVZ), also known as basal progenitor cells
(BP cells) [61-64]. In a study using Xenopus embryo,
Peng et al reported that exposure to ethanol reduced
the expression of several regulators of development
including Xenopus Pax6 (xPAX6) more than 90%, which
might be related to the microcephaly [65]. More
recently, similar findings were reported with pregnant
Wistar rats and their offsprings [66]. Obviously, these
results are inconsistent with our results, which showed
increase in Pax6 level by ethanol treatment both in vivo
and in vitro. The most important difference of the pre-
vious experiments and ours might be the difference in
the route of ethanol treatment. In the study of Aronne
et al., they treated pregnant Wistar rats with ethanol by
intraperitoneal injection (3.5 g/kg) from gestational day
10 to 18 (G10-G18). Interestingly, they found that fetal
weights and cerebral cortex thickness were significantly
lower in G18 prenatally ethanol exposed rat fetuses than
in control fetuses as well as neural tube defects. In our
study, we used gastric intubation protocol to mimic
actual binge drinking situation and did not found
defects in weight gain and any other physical
malformations suggesting that our protocol is much
milder compared to that of other researchers, although
it is also possible that species difference may account
for the different results. Whether there is biphasic bell
shaped concentration response curve for the expression
level of Pax6 and the resulting neurodevelopmental con-
sequences, would be a intriguing and must be answered
question to further extend our understanding about the
effect of parental alcohol consumption on the neurobio-
logical phenotype in offsprings.
In the present study, prenatal ethanol promoted exci-
tatory neuronal differentiation, possibly via increased
expression of Pax6, Ngn2 and NeuroD. Increasing the
numerical ratio of excitatory/inhibitory cells can lead to
a hyper-excitable state, which might be related to the
hyperactivity symptoms observed in FASD patients. In
fact, defects in either the production or migration of
cortical GABAergic neurons can lead to decreased num-
bers of cortical GABAergic neurons, which result in a
hyper-excitable cortex [67]. Mutations in GAD65, which
may also induce the reduction of inhibition in the
mouse cerebral cortex, interfere in the maturation of
binocular vision [68]. After perinatal early exposure to
ethanol, the expression of GABAA receptor or GABA
synaptic proteins as well as GABAergic synaptic trans-
mission has been reported to be impaired [52,69,70].
Fetal exposure to alcohol is also related to a higher sus-
ceptibility to convulsions. Recently, it has been sug-
gested that genetically epilepsy prone rats (GEPRs)
display susceptibility to audiogenic seizure after fetal
exposure to ethanol while there is general reduction in
susceptibility against pentylenetetrazole-induced seizure
compared to cognate control [71].
Although the mechanism for molecular signaling path-
way directly modulating the ratio of excitatory/inhibitory
neuron is unclear yet, the results from the present study
may suggest that ethanol modulates the expression of
key transcriptional factors involved in the excitatory
neuronal differentiation. Whether the modulation of
Pax6, Ngn2 and NeuroD by prenatal ethanol treatment
is causally related to the regulation of excitatory neuro-
nal differentiation and to hyperactive neuronal pheno-
type should be investigated further in the future study.
Conclusions
In this study, we demonstrated that ethanol exposure
suppressed the proliferation of NPCs and affected exci-
tatory/inhibitory neuronal subtype differentiation.
Decreased proliferation of NPCs by ethanol was identi-
fied using BrdU incorporation, pH3 immunostaining
and FACS analysis. Ethanol induced glutamatergic neu-
ronal differentiation, possibly via transient increase in
the expression of Pax6, Ngn2 and NeuroD with conco-
mitant decrease in the expression of Mash1. Similar
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well as glutamatergic neuronal differentiation was
shown using in vivo model. These results suggest that
ethanol-induced hyper-differentiation of glutamatergic
neuron via Pax6 pathway may underlie the hyper-excit-
ability phenotype such as hyperactivity or seizure sus-
ceptibility in FASD, which may provide additional
insights into the understanding of neurological aspects
of FASD and devising pharmacological and molecular
biological methods leading to the better treatment
options.
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